Editorial board

Editorial Advisory Board:
Allen MS, Mayo Clinic, USA
Ciardiello F, Seconda Università degli Studi di Napoli, Italy
Fong KM, University of Queensland, Australia
Friedberg JS,University of Pennsylvania, USA
Grunenwald D, University of Paris VI, France
Henschke CI, Mount Sinai School of Medicine, USA
Hiraoka M, Kyoto University, Japan
Jalal S, Indiana University, USA
Lara Jr PN, University of California Davis Cancer Center, USA
Lee JM, Ronald Reagan UCLA Medical Center, USA
Lee S-M, University College London, UK
MacManus M, Peter MacCallum Cancer Centre, Australia
Mason L, Brighton & Sussex University Hospitals NHS Trust, UK
Mulshine JL, Rush University Medical Center, USA
Nackaerts K, University Hospital Gasthuisberg, Belgium
O’Byrne KJ, Queensland University of Technology, Australia
Rossi A, SG Moscati Hospital, Italy
Saijo N, Kinki University School of Medicine, Japan
Santarpia M, University of Messina, Italy
Schmid-Bindert G, Oncology BU Eli Lilly,Heidelberg University,Germany
Spigel D, Sarah Cannon Research Institute, USA
Steliga M, University of Arkansas, USA
Stewart DJ, University of Ottawa, Canada
Thongprasert S, University of Chiang Mai, Thailand
von Pawel J, Asklepios Hospitals Harburg, Germany
Wu Y-L, Guangdong Lung Cancer Institute, China